MENU
Go to the list of all blogs
Vitalii Liubimov's Avatar
published in Blogs
Jan 07, 2019

Perkinelmer Just Hit Two Key Support Levels

Medical equipment manufacturer Perkinelmer (NYSE: PKI) has pulled back in the past few months, following the rest of the market. However, there could be good news for investors of Perkinelmer as the stock hit two key support levels in the last week.

We see on the daily chart that the stock dropped down to its 104-week moving average at its low last week, but then bounced sharply from there. The stock did the same thing back in early 2017 before jumping approximately 40% in the next six months.

The second support level that jumped out at me was the $72.50 area. We see that the stock struggled to get above that price in late 2017 before breaking through in early 2018. The stock then moved sideways from February through June, but it never closed a week below the $72.50 level during that stretch. I look for that price area to serve as strong support and look for the stock to bounce in the coming months.

In addition to the technical support, Perkinelmer has strong fundamental indicators as well. The company has seen earnings grow by 13% per year over the last three years. In the most recent quarterly report earnings grew by 23% while sales grew by 22%.

Even with the technical support and strong fundamentals, investors and analysts aren’t very bullish on the stock. There are 14 analysts following the stock and only five of them rank the stock as a “buy”. This leaves room for upgrades that can help propel the stock higher.

Related Ticker: RVTY

RVTY's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RVTY turned positive on November 21, 2025. Looking at past instances where RVTY's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 20, 2025. You may want to consider a long position or call options on RVTY as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

RVTY moved above its 50-day moving average on November 07, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RVTY advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 168 cases where RVTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RVTY moved out of overbought territory on October 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVTY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RVTY broke above its upper Bollinger Band on November 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.511) is normal, around the industry mean (12.407). P/E Ratio (50.655) is within average values for comparable stocks, (134.795). Projected Growth (PEG Ratio) (0.641) is also within normal values, averaging (1.915). Dividend Yield (0.003) settles around the average of (0.016) among similar stocks. P/S Ratio (4.144) is also within normal values, averaging (9.817).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RVTY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVTY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Exact Sciences Corp (NASDAQ:EXAS), Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 12.33B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 1%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 31%. SLDX experienced the highest price growth at 133%, while TDSGF experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 44%. For the same stocks of the Industry, the average monthly volume growth was 29% and the average quarterly volume growth was 94%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 63
Price Growth Rating: 53
SMR Rating: 79
Profit Risk Rating: 90
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
RVTY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RVTY showed earnings on October 27, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of analytical instruments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
940 Winter Street
Phone
+1 781 663-6900
Employees
11500
Web
https://www.revvity.com
Interact to see
Advertisement
On May 16, 2025, Moody's Ratings downgraded the United States' sovereign credit rating from its pristine AAA to Aa1, citing concerns over the nation's ballooning $36 trillion debt.
#trading
Tickeron, Inc., a leading provider of AI-driven trading tools, is thrilled to announce the launch of its token on the innovative Believe App, a platform revolutionizing community-driven funding.
#trading
Discover how AI-powered Dual Agent Trading Bots are transforming emotional trading into data-driven strategy. From mastering fear and greed to using inverse ETFs and pattern recognition, this article reveals how Tickeron's Agentic AI enables smarter, adaptive market moves.
#trading
Walmart’s stock is up nearly 54% in 2025, fueled by strong earnings, e-commerce growth, and investor confidence. This article explores Walmart’s financials, AI-driven analysis tools from Tickeron, and how traders are navigating market volatility with WMT.
#trading
Alphabet Inc. (GOOG, GOOGL), the parent company of Google, today released a financial update highlighting its performance and strategic initiatives as it approaches its Q2 2025 earnings report on July 29.
A routine Treasury bond auction shook markets on May 21, 2025, triggering an 80-point S&P 500 plunge as yields spiked above 5%. Explore what caused the sudden drop, how macroeconomic pressures played a role, and how Tickeron’s AI trading bots capitalized on the chaos.
#investment#trading
Ethereum ($ETH) is nearing a potential breakout above $4,000 as its 3-day chart forms a bullish Descending Broadening Wedge. With AI trading tools like Tickeron’s proven agents, traders are watching closely for a move that could define the next major crypto trend.
Bitcoin has officially hit $109,000 on May 21, 2025—exactly as predicted by Tickeron’s AI nearly two months ago. This milestone validates the platform’s AI accuracy and highlights how traders can use Tickeron’s AI Double Agents to navigate crypto market volatility with confidence.
Ethereum (ETH) is capturing the attention of traders and analysts alike, with its 3-day chart forming a Descending Broadening Wedge pattern—a classic technical setup that often precedes significant price movements.
#artificial_intelligence#trading
Tickeron, a leading provider of AI-driven trading tools, shared a bold prediction on X.com about Bitcoin’s (BTC) price trajectory.
#artificial_intelligence#trading
A turbulent week rocked global markets as the S&P 500 slid 3% following a U.S. credit downgrade, while Bitcoin surged past $111K and gold soared. Strong UK inflation and retail sales data added to the volatility, highlighting growing concerns over global economic stability.
Learn how to identify the four key market phases—Accumulation, Uptrend, Distribution, and Downtrend—and strategically trade each using Tickeron’s AI-powered Double Agent system. Discover how adaptive automation helps maximize gains and minimize risk across all market conditions.
#investment#artificial_intelligence
Learn how to identify the four key market phases—Accumulation, Uptrend, Distribution, and Downtrend—and strategically trade each using Tickeron’s AI-powered Double Agent system. Discover how adaptive automation helps maximize gains and minimize risk across all market conditions.
#artificial_intelligence#trading
Tickeron, a leader in AI-powered financial solutions, proudly announces the launch of its Double Agent Trading Bot, designed for trading Carpenter Technology Corporation (CRS) and Direxion Daily Semiconductor Bear 3x Shares (SOXS).
#artificial_intelligence
Apple Inc. (AAPL), a global leader in consumer electronics, continues to be a cornerstone of the technology sector, driving innovation and commanding significant market attention.
#artificial_intelligence
NVIDIA’s earnings on May 28 could jolt the tech sector. With market volatility rising, traders are turning to Tickeron’s AI Agent for real-time insights, predictive analytics, and dual-strategy trading tools to navigate potential price swings and seize market opportunities.
#artificial_intelligence
As the DOJ and FTC move to break up Google’s search dominance and impose AI investment oversight, the tech giant faces a pivotal legal battle that could reshape the digital and AI landscapes—creating major implications for investors, competitors, and consumers alike.
#artificial_intelligence
GameStop (GME) continues to captivate investors with its explosive volatility and strong retail sentiment. As AI tools highlight bullish signals and a possible breakout, traders weigh the risks of speculation against the potential rewards in May 2025.
#artificial_intelligence
Mastercard (MA) continues to impress investors with strong earnings, rising digital payments, and bullish AI-driven signals. Backed by robust financials and cutting-edge trading tools from Tickeron, MA stands out as a leader in the fintech space for 2025.